Literature DB >> 26361790

Individually modifiable risk factors to ameliorate cognitive aging: a systematic review and meta-analysis.

P Lehert1, P Villaseca2, E Hogervorst3, P M Maki4, V W Henderson5.   

Abstract

A number of health and lifestyle factors are thought to contribute to cognitive decline associated with age but cannot be easily modified by the individual patient. We identified 12 individually modifiable interventions that can be implemented during midlife or later with the potential to ameliorate cognitive aging. For ten of these, we used PubMed databases for a systematic review of long-duration (at least 6 months), randomized, controlled trials in midlife and older adults without dementia or mild cognitive impairment with objective measures of neuropsychological performance. Using network meta-analysis, we performed a quantitative synthesis for global cognition (primary outcome) and episodic memory (secondary outcome). Of 1038 publications identified by our search strategy, 24 eligible trials were included in the network meta-analysis. Results suggested that the Mediterranean diet supplemented by olive oil and tai chi exercise may improve global cognition, and the Mediterranean diet plus olive oil and soy isoflavone supplements may improve memory. Effect sizes were no more than small (standardized mean differences 0.11-0.22). Cognitive training may have cognitive benefit as well. Most individually modifiable risk factors have not yet been adequately studied. We conclude that some interventions that can be self-initiated by healthy midlife and older adults may ameliorate cognitive aging.

Entities:  

Keywords:  COGNITION; COGNITIVE ACTIVITY; COGNITIVE AGING; DEHYDROEPIANDROSTERONE; FOLATE; GINKGO BILOBA; ISOFLAVONES; MEDITERRANEAN DIET; MEMORY; MENOPAUSAL HORMONE THERAPY; META-ANALYSIS; MINDFULNESS; OMEGA-3 FATTY ACIDS; PHYSICAL EXERCISE; SOCIAL ENGAGEMENT; SYSTEMATIC REVIEW; TAI CHI; VITAMIN B12; VITAMIN D

Mesh:

Substances:

Year:  2015        PMID: 26361790      PMCID: PMC5199766          DOI: 10.3109/13697137.2015.1078106

Source DB:  PubMed          Journal:  Climacteric        ISSN: 1369-7137            Impact factor:   3.005


  78 in total

Review 1.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

2.  Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life.

Authors:  Kristine Yaffe; Eric Vittinghoff; Kristine E Ensrud; Karen C Johnson; Susan Diem; Vladimir Hanes; Deborah Grady
Journal:  Arch Neurol       Date:  2006-07

Review 3.  Effect of homocysteine lowering treatment on cognitive function: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Andrew H Ford; Osvaldo P Almeida
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

4.  Brain aging and midlife tofu consumption.

Authors:  L R White; H Petrovitch; G W Ross; K Masaki; J Hardman; J Nelson; D Davis; W Markesbery
Journal:  J Am Coll Nutr       Date:  2000-04       Impact factor: 3.169

5.  Effect of 2-y n-3 long-chain polyunsaturated fatty acid supplementation on cognitive function in older people: a randomized, double-blind, controlled trial.

Authors:  Alan D Dangour; Elizabeth Allen; Diana Elbourne; Nicky Fasey; Astrid E Fletcher; Pollyanna Hardy; Graham E Holder; Rosemary Knight; Louise Letley; Marcus Richards; Ricardo Uauy
Journal:  Am J Clin Nutr       Date:  2010-04-21       Impact factor: 7.045

6.  Mediterranean diet and cognitive function in older age.

Authors:  Cécilia Samieri; Francine Grodstein; Bernard A Rosner; Jae H Kang; Nancy R Cook; Joann E Manson; Julie E Buring; Walter C Willett; Olivia I Okereke
Journal:  Epidemiology       Date:  2013-07       Impact factor: 4.822

7.  Effects of dehydroepiandrosterone supplementation on cognitive function and quality of life: the DHEA and Well-Ness (DAWN) Trial.

Authors:  Donna Kritz-Silverstein; Denise von Mühlen; Gail A Laughlin; Ricki Bettencourt
Journal:  J Am Geriatr Soc       Date:  2008-05-14       Impact factor: 5.562

8.  Virgin olive oil supplementation and long-term cognition: the PREDIMED-NAVARRA randomized, trial.

Authors:  E H Martínez-Lapiscina; P Clavero; E Toledo; B San Julián; A Sanchez-Tainta; D Corella; R M Lamuela-Raventós; J A Martínez; M Á Martínez-Gonzalez
Journal:  J Nutr Health Aging       Date:  2013       Impact factor: 4.075

Review 9.  Alzheimer's disease: review of hormone therapy trials and implications for treatment and prevention after menopause.

Authors:  Victor W Henderson
Journal:  J Steroid Biochem Mol Biol       Date:  2013-05-28       Impact factor: 4.292

Review 10.  Dehydroepiandrosterone (DHEA) supplementation for cognitive function in healthy elderly people.

Authors:  J Grimley Evans; R Malouf; F Huppert; J K van Niekerk
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18
View more
  21 in total

Review 1.  The effects of aging on auditory cortical function.

Authors:  Gregg Recanzone
Journal:  Hear Res       Date:  2018-05-23       Impact factor: 3.208

2.  An International Evaluation of Cognitive Reserve and Memory Changes in Early Old Age in 10 European Countries.

Authors:  Dorina Cadar; Annie Robitaille; Sean Clouston; Scott M Hofer; Andrea M Piccinin; Graciela Muniz-Terrera
Journal:  Neuroepidemiology       Date:  2017-02-21       Impact factor: 3.282

Review 3.  Strategies for Preventing Cognitive Decline in Healthy Older Adults.

Authors:  Julie A Dumas
Journal:  Can J Psychiatry       Date:  2017-07-13       Impact factor: 4.356

4.  Perspective: Network Meta-analysis Reaches Nutrition Research: Current Status, Scientific Concepts, and Future Directions.

Authors:  Lukas Schwingshackl; Guido Schwarzer; Gerta Rücker; Joerg J Meerpohl
Journal:  Adv Nutr       Date:  2019-09-01       Impact factor: 8.701

5.  Neurocognition in treatment-resistant hypertension: profile and associations with cardiovascular biomarkers.

Authors:  Patrick J Smith; James A Blumenthal; Alan L Hinderliter; Stephanie M Mabe; Jeanne E Schwartz; Forgive Avorgbedor; Andrew Sherwood
Journal:  J Hypertens       Date:  2019-05       Impact factor: 4.844

6.  Microvascular Endothelial Function and Neurocognition Among Adults With Major Depressive Disorder.

Authors:  Patrick J Smith; James A Blumenthal; Alan L Hinderliter; Lana L Watkins; Benson M Hoffman; Andrew Sherwood
Journal:  Am J Geriatr Psychiatry       Date:  2018-06-28       Impact factor: 4.105

7.  Mild Cognitive Impairment, Neurodegeneration, and Personalized Lifestyle Medicine.

Authors:  Jeffrey Bland
Journal:  Integr Med (Encinitas)       Date:  2016-04

8.  Circulating B-vitamin biomarkers and B-vitamin supplement use in relation to quality of life in patients with colorectal cancer: results from the FOCUS consortium.

Authors:  Janna L Koole; Martijn J L Bours; Anne J M R Geijsen; Biljana Gigic; Arve Ulvik; Dieuwertje E Kok; Stefanie Brezina; Jennifer Ose; Andreas Baierl; Jürgen Böhm; Hermann Brenner; Stéphanie O Breukink; Jenny Chang-Claude; Fränzel J B van Duijnhoven; Peter van Duijvendijk; Tanja Gumpenberger; Nina Habermann; Henk K van Halteren; Michael Hoffmeister; Andreana N Holowatyj; Maryska L G Janssen-Heijnen; Eric T P Keulen; Rama Kiblawi; Flip M Kruyt; Christopher I Li; Tengda Lin; Øivind Midttun; Anita R Peoples; Eline H van Roekel; Martin A Schneider; Petra Schrotz-King; Alexis B Ulrich; Kathy Vickers; Evertine Wesselink; Johannes H W de Wilt; Andrea Gsur; Per M Ueland; Cornelia M Ulrich; Ellen Kampman; Matty P Weijenberg
Journal:  Am J Clin Nutr       Date:  2021-06-01       Impact factor: 7.045

9.  The Efficacy of Cognitive Intervention in Mild Cognitive Impairment (MCI): a Meta-Analysis of Outcomes on Neuropsychological Measures.

Authors:  Dale S Sherman; Justin Mauser; Miriam Nuno; Dean Sherzai
Journal:  Neuropsychol Rev       Date:  2017-12-27       Impact factor: 7.444

Review 10.  A Game a Day Keeps Cognitive Decline Away? A Systematic Review and Meta-Analysis of Commercially-Available Brain Training Programs in Healthy and Cognitively Impaired Older Adults.

Authors:  Lan Nguyen; Karen Murphy; Glenda Andrews
Journal:  Neuropsychol Rev       Date:  2021-07-12       Impact factor: 6.940

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.